Screening for HIV-specific T-cell responses using overlapping 15-mer peptide pools or optimized epitopes

Area of Science:

• Immunology
• Virology
• Vaccinology

Background:

• The Interferon-gamma (IFN-y) enzyme-linked immunospot (ELISpot) assay is a key tool for measuring HIV-specific CD8 T-cell immune responses.
• Accurate mapping of these responses is crucial for evaluating the efficacy of HIV vaccine candidates.

Purpose of the Study:

• To compare the effectiveness of overlapping 15-mer peptide pools versus optimized CD8 epitopes for screening ELISpot responses in individuals with HIV.
• To identify potential limitations of using 15-mer pools in the context of HIV immunology research and vaccine development.

Main Methods:

• Utilized IFN-y ELISpot assays to analyze T-cell responses in HIV-infected individuals.
• Compared the detection rates of overlapping 15-mer peptide pools against optimized CD8 epitopes.
• Evaluated the impact of epitope location (N-terminus, C-terminus, central) within the 15-mer pool on response detection.

Main Results:

• Overlapping 15-mer pools successfully identified responses to previously undefined epitopes.
• However, these pools frequently failed to detect low-level T-cell responses to predefined epitopes.
• Epitope location within the 15-mer significantly influenced detection, with central epitopes being more likely to be missed.

Conclusions:

• The choice of peptide pool strategy in ELISpot assays can affect the comprehensive mapping of HIV-specific CD8 T-cell responses.
• Limitations in detecting low-level or centrally located epitopes using 15-mer pools necessitate careful consideration during the monitoring of HIV vaccine trials.
• Optimized epitope selection may be crucial for sensitive detection of T-cell responses in HIV research and clinical trials.